Loss of 4q21.23-22.1 Is a Prognostic Marker for Disease Free and Overall Survival in Non-Small Cell Lung Cancer

This study was performed to assess the prognostic relevance of genomic aberrations at chromosome 4q in NSCLC patients. We have previously identified copy number changes at 4q12-q32 to be significantly associated with the early hematogenous dissemination of non-small cell lung cancer (NSCLC), and now...

Descripción completa

Detalles Bibliográficos
Autores principales: Uzunoglu, Faik G., Dethlefsen, Ebba, Hanssen, Annkathrin, Wrage, Michaela, Deutsch, Lena, Harms-Effenberger, Katharina, Vashist, Yogesh K., Reeh, Matthias, Sauter, Guido, Simon, Ronald, Bockhorn, Maximillian, Pantel, Klaus, Izbicki, Jakob R., Wikman, Harriet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263470/
https://www.ncbi.nlm.nih.gov/pubmed/25501003
http://dx.doi.org/10.1371/journal.pone.0113315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263470/
https://www.ncbi.nlm.nih.gov/pubmed/25501003
http://dx.doi.org/10.1371/journal.pone.0113315

Ejemplares similares